THE BALANCE

Private admissions

Let’s talk about your next step.

Speak with our admissions team about treatment for you or someone you care about.

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager
Abdullah Boulad, Founder & CEO

Prefer to speak with our founder?

Abdullah Boulad · Founder & CEO

Clinical resource

Statins and Alcohol

Statins reduce cardiovascular risk. Alcohol advice depends on the medicine, drinking pattern and liver health; learn about monitoring, warning signs and when to seek help.

Clinically reviewed byDr. Sarah Boss, MD
Stone residence with a swimming pool, lawn and palm trees

Quick Summary

  • Statins lower LDL cholesterol and cardiovascular risk. Heavy drinking, liver disease and interacting medicines require prescriber review. Report unexplained muscle symptoms or jaundice promptly; do not stop a statin to drink, and seek medical support before stopping alcohol if physically dependent.

Alcohol can interact with medicines, and heavy drinking can damage the liver and heart. For people experiencing alcohol addiction, a prescriber should assess drinking patterns, liver health and other medicines when recommending a statin.

Statins lower LDL cholesterol and reduce the risk of heart attacks and strokes in suitable patients. Alcohol advice depends on the specific medicine, amount consumed and individual health. Heavy drinking warrants a discussion with your prescriber; do not stop a prescribed statin or change its dose simply to drink alcohol.

This article will discuss statins and alcohol, whether they are safe to mix, what side effects are likely to occur, and the warning signs to watch out for in case of possible body damage.

A statin prescription does not automatically mean that all alcohol is forbidden. However, heavy drinking can harm the liver and cardiovascular system, and may increase some medicine-related risks. Follow your prescriber’s individual advice. Statins reduce cardiovascular risk; a specific alcohol–statin interaction should not be assumed to cause a heart attack or stroke.

Possible statin side effects include the following. These symptoms do not, by themselves, establish an interaction with alcohol:

  • Sleep problems
  • Bloating or indigestion
  • Nausea
  • Diarrhea or constipation
  • Headaches
  • Dizziness
  • Muscle aches

Many people tolerate statins well. Discuss persistent or troublesome symptoms with your prescriber, who can assess other causes and consider a different medicine or dose. The following issues require particular attention:

Myositis or Myalgia

Myalgia means muscle pain; myositis means muscle inflammation. Unexplained pain, tenderness, cramps or weakness should be reported promptly. Serious muscle breakdown, called rhabdomyolysis, is rare but can injure the kidneys. Severe muscle symptoms, particularly with fever or red-brown urine, need urgent assessment. Some interacting medicines increase this risk.

Increased Blood Sugar Levels

Statins can slightly raise blood glucose and the likelihood of type 2 diabetes, particularly in people already at higher risk. For most eligible patients, cardiovascular benefits outweigh this risk. Your clinician can decide whether glucose monitoring is appropriate; do not stop treatment on your own because of this possibility.

Memory Loss

Memory problems or confusion need assessment and can have several causes, including alcohol and other medicines. Evidence does not establish these symptoms as a specific effect of combining alcohol with statins. Discuss new or persistent symptoms with a clinician rather than assuming the statin is responsible.

Statins can cause mild increases in liver enzymes, while clinically apparent liver injury is rare. Abnormal results can also reflect alcohol use or another illness. A clinician should interpret them in context and arrange appropriate follow-up.

Liver Enzymes and Statins

Liver blood tests are usually checked before statin treatment. UK monitoring guidance includes checks around 2–3 months after starting or changing treatment and at 12 months; further liver tests are generally guided by clinical need. Plans vary by country, product and individual risk. Mild enzyme elevations do not necessarily mean liver injury.

Heavy alcohol use can damage the liver and alter blood-test results. Tell your clinician how much you drink so that abnormal results and treatment choices can be assessed appropriately.

Liver Injury and Statins

Clinically apparent statin-related liver injury is rare. Report jaundice, dark urine or other concerning symptoms promptly. Different patterns of injury have been described, including rare autoimmune-like cases; severe injury should not be presented as usually autoimmune. A clinician must assess other possible causes, including alcohol.

Potential Benefits of Statins for Liver

Stable chronic liver disease does not automatically rule out a statin when it is needed to reduce cardiovascular risk. The decision depends on liver function, symptoms, other medicines and the expected benefit, and may require specialist advice.

Research into statins and liver outcomes does not establish them as a treatment for alcohol-related cirrhosis or a guarantee against liver failure. They should be prescribed for an appropriate indication following an individual assessment.

Active liver disease and interactions with hepatitis medicines require prescriber review. Do not add a statin to improve hepatitis treatment or assume that combining these medicines is safe without checking the exact products.

Seek prompt medical advice for unexplained muscle symptoms or signs of liver injury. Severe pain or weakness, jaundice, dark urine or severe abdominal pain need urgent assessment. Trouble breathing, swelling of the lips or throat, or collapse requires emergency help. The following symptoms can have several causes:

  • Severe or unexplained muscle pain
  • Breathing difficulty or swelling of the throat
  • Severe abdominal pain
  • Fever with muscle symptoms
  • Persistent muscle cramps
  • Persistent nausea or vomiting
  • Loss of appetite with other concerning symptoms
  • Marked muscle weakness
  • Jaundice or dark/red-brown urine

Statins can offer substantial cardiovascular benefit. Heavy alcohol use adds health risks and should be discussed honestly with the prescribing clinician. Advice depends on the statin, liver health, other conditions and other medicines.

If drinking is difficult to control, ask your doctor or an alcohol service for support. Physical alcohol dependence can make sudden withdrawal dangerous: seek medical advice before stopping or sharply reducing alcohol. Hallucinations, seizures or severe withdrawal symptoms require emergency help.

Questions

Frequently Asked Questions

What are the names of some common statins? Are they all the same?
Statin intensity can be low, moderate or high and depends on the medicine and dose. Different products are not interchangeable without prescriber advice. Examples include the following; availability varies by country:
 
Atorvastatin
Pravastatin
Rosuvastatin
Fluvastatin
Lovastatin
Pitavastatin
Simvastatin
Are there any foods that I should avoid while taking statins?
Grapefruit affects some statins, but not all. Avoid it with simvastatin, and check the advice for the exact medicine you take. NHS atorvastatin guidance advises avoiding too much grapefruit juice. Ask a pharmacist rather than applying one rule to every statin.
Can you mix statin and alcohol?
Advice depends on the statin, your drinking pattern and liver health. Heavy drinking warrants prescriber review. UK liver monitoring commonly includes baseline tests, another check around 2–3 months after starting or changing treatment, and a check at 12 months; ongoing tests depend on clinical need. Testing every three months indefinitely is not a universal requirement. Do not stop a prescribed statin to drink alcohol.
What are some things to remember while taking statins and alcohol?
Be honest about the amount and pattern of alcohol use, including binge drinking.
 
Follow individual advice about alcohol and your specific statin.
Report unexplained muscle symptoms or signs of liver injury promptly.
Check interactions with other medicines and supplements.
Do not change treatment simply to drink.
 
If you may be physically dependent on alcohol, get medical advice before stopping or sharply reducing it. Your clinician can arrange support and assess withdrawal risk.
Who is at risk of mixing alcohol and atorvastatin?
Heavy alcohol use, active liver disease, certain interacting medicines, untreated thyroid disease and a history of muscle problems may affect treatment decisions.
 
Kidney disease and older age do not automatically exclude all statins; the medicine and dose need individual review.
Pregnancy or plans to conceive should be discussed promptly, because statins are generally not recommended in pregnancy, with limited specialist exceptions.
Breastfeeding advice varies by product and local guidance; consult your prescriber or pharmacist.
Do not start, stop or change a statin on your own.
Can I mix atorvastatin with other prescription medications or illicit drugs?
Some medicines interact with atorvastatin, including certain antibiotics, antifungals, HIV or hepatitis treatments, and other cholesterol medicines. The effect depends on the exact product and dose; not every medicine in these groups has the same risk.
 
Ask a pharmacist or prescriber to check all prescriptions, over-the-counter medicines, supplements and any nonmedical drug use. Do not assume that an illicit drug is safe with a statin, or adjust your dose yourself.

Editorial evidence

Evidence & sources

Selected clinical guidelines, peer-reviewed research, and public-health sources used in this article.

01National Institute for Health and Care Excellence. Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238).View source
02NHS Specialist Pharmacy Service. Statins monitoring.View source
03NHS Specialist Pharmacy Service. Using statins in liver impairment.View source
View all 16 sourcesShow fewer sources
05Cholesterol Treatment Trialists’ (CTT) Collaboration. (2010). Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. The Lancet.View source
06Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012). The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline. Hepatology.View source
09National Institute on Alcohol Abuse and Alcoholism. Alcohol’s effects on the body.View source
10Centers for Disease Control and Prevention. Alcohol use and your health.View source
11U.S. Food and Drug Administration. (2021). Removal of the strongest warning against statin use during pregnancy; most pregnant patients should still stop statins.View source
13National Institute of Diabetes and Digestive and Kidney Diseases. Atorvastatin. LiverTox.View source
14Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Jr., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., Nordestgaard, B. G., Shepherd, J., Willerson, J. T., & Glynn, R. J. (2008). Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine.View source
15National Heart, Lung, and Blood Institute. Blood cholesterol.View source
16Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., McBride, P., Schwartz, J. S., Shero, S. T., Smith, S. C., Jr., Watson, K., & Wilson, P. W. F. (2014). 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation.View source
What this includes
01

Clinical context

Clear information is framed around complex and co-occurring presentations.

02

Individual factors

Assessment remains essential because needs and risks differ from person to person.

03

Next steps

A confidential conversation can help clarify the most appropriate route forward.

Not sure where the situation fits?

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager

A confidential first conversation can help clarify the presentation and whether our setting is appropriate.

THE BALANCE
A PLACE TO BEGIN

Ask about our care